Literature DB >> 17194758

Cyclin-dependent kinase 5 modulates nociceptive signaling through direct phosphorylation of transient receptor potential vanilloid 1.

Tej K Pareek1, Jason Keller, Sashi Kesavapany, Nitin Agarwal, Rohini Kuner, Harish C Pant, Michael J Iadarola, Roscoe O Brady, Ashok B Kulkarni.   

Abstract

Transient receptor potential vanilloid 1 (TRPV1), a ligand-gated cation channel highly expressed in small-diameter sensory neurons, is activated by heat, protons, and capsaicin. The phosphorylation of TRPV1 provides a versatile regulation of intracellular calcium levels and is critical for TRPV1 function in responding to a pain stimulus. We have previously reported that cyclin-dependent kinase 5 (Cdk5) activity regulates nociceptive signaling. In this article we report that the Cdk5-mediated phosphorylation of TRPV1 at threonine-407 can modulate agonist-induced calcium influx. Inhibition of Cdk5 activity in cultured dorsal root ganglia neurons resulted in a significant reduction of TRPV1-mediated calcium influx, and this effect could be reversed by restoring Cdk5 activity. Primary nociceptor-specific Cdk5 conditional-knockout mice showed reduced TRPV1 phosphorylation, resulting in significant hypoalgesia. Thus, the present study indicates that Cdk5-mediated TRPV1 phosphorylation is important in the regulation of pain signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17194758      PMCID: PMC1752192          DOI: 10.1073/pnas.0609916104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

Review 1.  Activation and activators of TRPV1 and their pharmaceutical implication.

Authors:  Young-Ger Suh; Uhtaek Oh
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

2.  Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia.

Authors:  J B Davis; J Gray; M J Gunthorpe; J P Hatcher; P T Davey; P Overend; M H Harries; J Latcham; C Clapham; K Atkinson; S A Hughes; K Rance; E Grau; A J Harper; P L Pugh; D C Rogers; S Bingham; A Randall; S A Sheardown
Journal:  Nature       Date:  2000-05-11       Impact factor: 49.962

3.  Aberrant motor axon projection, acetylcholine receptor clustering, and neurotransmission in cyclin-dependent kinase 5 null mice.

Authors:  Amy K Y Fu; Fanny C F Ip; Wing-Yu Fu; Janet Cheung; Jerry H Wang; Wing-Ho Yung; Nancy Y Ip
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

4.  Intrathecal administration of roscovitine inhibits Cdk5 activity and attenuates formalin-induced nociceptive response in rats.

Authors:  Cheng-haung Wang; Wen-ying Chou; Kung-sheng Hung; Bruno Jawan; Cheng-nann Lu; Jong-kang Liu; Yi-ping Hung; Tsung-hsing Lee
Journal:  Acta Pharmacol Sin       Date:  2005-01       Impact factor: 6.150

5.  Mechanism of CDK5/p25 binding by CDK inhibitors.

Authors:  Marina Mapelli; Lucia Massimiliano; Claudia Crovace; Markus A Seeliger; Li-Huei Tsai; Laurent Meijer; Andrea Musacchio
Journal:  J Med Chem       Date:  2005-02-10       Impact factor: 7.446

6.  Cyclin-dependent kinase 5 activity regulates pain signaling.

Authors:  Tej K Pareek; Jason Keller; Sashi Kesavapany; Harish C Pant; Michael J Iadarola; Roscoe O Brady; Ashok B Kulkarni
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

7.  Phosphorylation of WAVE1 regulates actin polymerization and dendritic spine morphology.

Authors:  Yong Kim; Jee Young Sung; Ilaria Ceglia; Ko-Woon Lee; Jung-Hyuck Ahn; Jonathan M Halford; Amie M Kim; Seung P Kwak; Jong Bae Park; Sung Ho Ryu; Annette Schenck; Barbara Bardoni; John D Scott; Angus C Nairn; Paul Greengard
Journal:  Nature       Date:  2006-07-16       Impact factor: 49.962

8.  Impaired nociception and pain sensation in mice lacking the capsaicin receptor.

Authors:  M J Caterina; A Leffler; A B Malmberg; W J Martin; J Trafton; K R Petersen-Zeitz; M Koltzenburg; A I Basbaum; D Julius
Journal:  Science       Date:  2000-04-14       Impact factor: 47.728

Review 9.  TRP channels in disease.

Authors:  Bernd Nilius; Thomas Voets; John Peters
Journal:  Sci STKE       Date:  2005-08-02

Review 10.  Cdk5: a new player in pain signaling.

Authors:  Tej K Pareek; Ashok B Kulkarni
Journal:  Cell Cycle       Date:  2006-03-15       Impact factor: 4.534

View more
  50 in total

1.  Structure-activity relationships of 1,4-dihydropyridines that act as enhancers of the vanilloid receptor 1 (TRPV1).

Authors:  Eun Joo Roh; Jason M Keller; Zoltan Olah; Michael J Iadarola; Kenneth A Jacobson
Journal:  Bioorg Med Chem       Date:  2008-08-26       Impact factor: 3.641

2.  The Cdk5 kinase downregulates ATP-gated ionotropic P2X3 receptor function via serine phosphorylation.

Authors:  Asha Nair; Manuela Simonetti; Elsa Fabbretti; Andrea Nistri
Journal:  Cell Mol Neurobiol       Date:  2009-12-04       Impact factor: 5.046

3.  Cyclin-dependent kinase 5 is amplified and overexpressed in pancreatic cancer and activated by mutant K-Ras.

Authors:  John P Eggers; Paul M Grandgenett; Eric C Collisson; Michelle E Lewallen; Jarrod Tremayne; Pankaj K Singh; Benjamin J Swanson; Judy M Andersen; Thomas C Caffrey; Robin R High; Michel Ouellette; Michael A Hollingsworth
Journal:  Clin Cancer Res       Date:  2011-08-08       Impact factor: 12.531

Review 4.  Cdk5: mediator of neuronal development, death and the response to DNA damage.

Authors:  Jinqiu Zhu; Wenming Li; Zixu Mao
Journal:  Mech Ageing Dev       Date:  2011-05-11       Impact factor: 5.432

Review 5.  Sensory TRP channels: the key transducers of nociception and pain.

Authors:  Aaron D Mickle; Andrew J Shepherd; Durga P Mohapatra
Journal:  Prog Mol Biol Transl Sci       Date:  2015-02-12       Impact factor: 3.622

6.  Differences in metabolite-detecting, adrenergic, and immune gene expression after moderate exercise in patients with chronic fatigue syndrome, patients with multiple sclerosis, and healthy controls.

Authors:  Andrea T White; Alan R Light; Ronald W Hughen; Timothy A Vanhaitsma; Kathleen C Light
Journal:  Psychosom Med       Date:  2011-12-30       Impact factor: 4.312

Review 7.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

8.  Cyclin-dependent kinase 5 activity is required for T cell activation and induction of experimental autoimmune encephalomyelitis.

Authors:  Tej K Pareek; Eric Lam; Xiaojing Zheng; David Askew; Ashok B Kulkarni; Mark R Chance; Alex Y Huang; Kenneth R Cooke; John J Letterio
Journal:  J Exp Med       Date:  2010-10-11       Impact factor: 14.307

9.  Conditional deletion of neuronal cyclin-dependent kinase 5 in developing forebrain results in microglial activation and neurodegeneration.

Authors:  Satoru Takahashi; Toshio Ohshima; Motoyuki Hirasawa; Tej K Pareek; Thomas H Bugge; Alexei Morozov; Kenji Fujieda; Roscoe O Brady; Ashok B Kulkarni
Journal:  Am J Pathol       Date:  2009-11-30       Impact factor: 4.307

10.  Tumor necrosis factor-alpha regulates cyclin-dependent kinase 5 activity during pain signaling through transcriptional activation of p35.

Authors:  Elias Utreras; Akira Futatsugi; Parvathi Rudrabhatla; Jason Keller; Michael J Iadarola; Harish C Pant; Ashok B Kulkarni
Journal:  J Biol Chem       Date:  2008-12-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.